Trial · NCT03228680
Results by group156
Each measurement the trial posted, group by group, in the words and numbers it posted.
21 to 40 of 156
Download this page as JSON| Outcome | Group | Category | Value | Spread | Units |
|---|---|---|---|---|---|
| Proportion of Participants With <4, 4-7, 8-14, 15-19 and ≥20 Oocytes Retrieved | FE 999049 (Follitropin Delta) | Targeted response (8-14 oocytes) | 40.8 | percentage of participants | |
| Proportion of Participants With <4, 4-7, 8-14, 15-19 and ≥20 Oocytes Retrieved | FOLLISTIM (Follitropin Beta) | Targeted response (8-14 oocytes) | 42.8 | percentage of participants | |
| Proportion of Participants With <4, 4-7, 8-14, 15-19 and ≥20 Oocytes Retrieved | FE 999049 (Follitropin Delta) | Hyperresponse (15-19 oocytes) | 10.1 | percentage of participants | |
| Proportion of Participants With <4, 4-7, 8-14, 15-19 and ≥20 Oocytes Retrieved | FOLLISTIM (Follitropin Beta) | Hyperresponse (15-19 oocytes) | 14.5 | percentage of participants | |
| Proportion of Participants With <4, 4-7, 8-14, 15-19 and ≥20 Oocytes Retrieved | FE 999049 (Follitropin Delta) | Severe hyperresponse (≥ 20 oocytes) | 4.7 | percentage of participants | |
| Proportion of Participants With <4, 4-7, 8-14, 15-19 and ≥20 Oocytes Retrieved | FOLLISTIM (Follitropin Beta) | Severe hyperresponse (≥ 20 oocytes) | 11.0 | percentage of participants | |
| Proportion of Participants With Extreme Ovarian Responses (Defined as <4, ≥15 or ≥20 Oocytes Retrieved) in Risk Population | FE 999049 (Follitropin Delta) | AMH < 15 pmol/L (<4 oocytes retrieved) | 11.6 | percentage of participants | |
| Proportion of Participants With Extreme Ovarian Responses (Defined as <4, ≥15 or ≥20 Oocytes Retrieved) in Risk Population | FOLLISTIM (Follitropin Beta) | AMH < 15 pmol/L (<4 oocytes retrieved) | 12.3 | percentage of participants | |
| Proportion of Participants With Extreme Ovarian Responses (Defined as <4, ≥15 or ≥20 Oocytes Retrieved) in Risk Population | FE 999049 (Follitropin Delta) | AMH >= 15 pmol/L (>=15 oocytes retrieved) | 22.0 | percentage of participants | |
| Proportion of Participants With Extreme Ovarian Responses (Defined as <4, ≥15 or ≥20 Oocytes Retrieved) in Risk Population | FOLLISTIM (Follitropin Beta) | AMH >= 15 pmol/L (>=15 oocytes retrieved) | 42.0 | percentage of participants | |
| Proportion of Participants With Extreme Ovarian Responses (Defined as <4, ≥15 or ≥20 Oocytes Retrieved) in Risk Population | FE 999049 (Follitropin Delta) | AMH >= 15 pmol/L (>=20 oocytes retrieved) | 8.0 | percentage of participants | |
| Proportion of Participants With Extreme Ovarian Responses (Defined as <4, ≥15 or ≥20 Oocytes Retrieved) in Risk Population | FOLLISTIM (Follitropin Beta) | AMH >= 15 pmol/L (>=20 oocytes retrieved) | 19.0 | percentage of participants | |
| Proportion of Participants With Preventive Interventions for Early Ovarian Hyperstimulation Syndrome (OHSS) | FE 999049 (Follitropin Delta) | Cycle cancellation | 0 | percentage of participants | |
| Proportion of Participants With Preventive Interventions for Early Ovarian Hyperstimulation Syndrome (OHSS) | FOLLISTIM (Follitropin Beta) | Cycle cancellation | 1.1 | percentage of participants | |
| Proportion of Participants With Preventive Interventions for Early Ovarian Hyperstimulation Syndrome (OHSS) | FE 999049 (Follitropin Delta) | Triggering with GnRH agonist | 1.2 | percentage of participants | |
| Proportion of Participants With Preventive Interventions for Early Ovarian Hyperstimulation Syndrome (OHSS) | FOLLISTIM (Follitropin Beta) | Triggering with GnRH agonist | 1.1 | percentage of participants | |
| Proportion of Participants With Preventive Interventions for Early Ovarian Hyperstimulation Syndrome (OHSS) | FE 999049 (Follitropin Delta) | Administration of dopamine agonist | 0.6 | percentage of participants | |
| Proportion of Participants With Preventive Interventions for Early Ovarian Hyperstimulation Syndrome (OHSS) | FOLLISTIM (Follitropin Beta) | Administration of dopamine agonist | 1.7 | percentage of participants | |
| Proportions of Participants With Early OHSS (Including OHSS of Moderate/Severe Grade) and/or Preventive Interventions for Early OHSS | FE 999049 (Follitropin Delta) | Early OHSS (any grade) | 10.0 | percentage of participants | |
| Proportions of Participants With Early OHSS (Including OHSS of Moderate/Severe Grade) and/or Preventive Interventions for Early OHSS | FOLLISTIM (Follitropin Beta) | Early OHSS (any grade) | 18.6 | percentage of participants |
Source ClinicalTrials.govtrials-2026-11-12-0.5.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT03228680/results?page=2